Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CardieX Limited (AU:CDX)
ASX:CDX
Holding AU:CDX?
Track your performance easily
CDX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.05 - AU$0.13
Previous CloseAU$0.08
Volume9.88K
Average Volume (3M)277.20K
Market Cap
AU$24.12M
Enterprise ValueAU$24.80M
Total Cash (Recent Filing)AU$1.46M
Total Debt (Recent Filing)AU$2.14M
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Feb 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares OutstandingN/A
10 Day Avg. Volume368,277
30 Day Avg. Volume277,197
Standard Deviation0.25
R-Squared0.12
Alpha-0.00365
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)12.43
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CardieX Limited News
PremiumCompany Announcements
CardieX Begins U.S. Pre-orders for CONNEQT Pulse
PremiumCompany Announcements
CardieX Limited Announces Annual General MeetingPremiumCompany Announcements
CardieX Stakeholder Regal Funds Alters Shareholding
PremiumCompany Announcements
CardieX Limited Reports Revenue Surge and Reduced Loss
PremiumCompany Announcements
CardieX Secures $1.12M Loan for R&D Initiatives
PremiumCompany Announcements
CardieX Sheds Light on Cardiovascular Biomarker Advances
PremiumCompany Announcements
CardieX Reports Record Revenue, Expands Market PresencePremiumCompany Announcements
CardieX Limited Faces Cash Flow ChallengesCDX FAQ
What was CardieX Limited’s price range in the past 12 months?
CardieX Limited lowest share price was AU$0.04 and its highest was AU$0.13 in the past 12 months.
What is CardieX Limited’s market cap?
Currently, no data Available
When is CardieX Limited’s upcoming earnings report date?
CardieX Limited’s upcoming earnings report date is Feb 27, 2025 which is in 114 days.
How were CardieX Limited’s earnings last quarter?
CardieX Limited released its earnings results on Aug 30, 2024. The company reported -AU$0.039 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.039.
Is CardieX Limited overvalued?
According to Wall Street analysts CardieX Limited’s price is currently Overvalued.
Does CardieX Limited pay dividends?
CardieX Limited does not currently pay dividends.
What is CardieX Limited’s EPS estimate?
CardieX Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CardieX Limited have?
CardieX Limited has 294,174,560 shares outstanding.
What happened to CardieX Limited’s price movement after its last earnings report?
CardieX Limited reported an EPS of -AU$0.039 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.769%.
Which hedge fund is a major shareholder of CardieX Limited?
Currently, no hedge funds are holding shares in AU:CDX
---
CardieX Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:CDX Sentiment 86%
Sector Average 72%
Sector Average 72%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
-399.46%
Trailing 12-Months
Asset Growth
-12.69%
Trailing 12-Months
Company Description
CardieX Limited
CardieX Ltd is a global health technology company, developing solutions for health disorders. Its AtCor Medical division develops and markets products for the early detection of target organ damage and management of a cardiovascular and renal disease. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia & Australia/New Zealand.
---
Technical Analysis
VolitionRX
―
Helius Medical Technologies
―
Alterity Therapeutics
―
CardieX Limited
―
Sanuwave Health
―
---